Publication | Open Access
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer
137
Citations
42
References
2020
Year
Oncogenic AgentMedicineHexosamine Biosynthesis PathwayTargetable LiabilityTumor SuppressorSystems BiologyCancer BiologyCell BiologyLung CancerCancer ResearchCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1